MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.

Standard

MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients. / Foote, C J; Greer, W; Kiberd, B A; Fraser, A; Lawen, J; Nashan, Björn; Belitsky, P.

In: TRANSPL P, Vol. 38, No. 9, 9, 2006, p. 2847-2849.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Foote, CJ, Greer, W, Kiberd, BA, Fraser, A, Lawen, J, Nashan, B & Belitsky, P 2006, 'MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.', TRANSPL P, vol. 38, no. 9, 9, pp. 2847-2849. <http://www.ncbi.nlm.nih.gov/pubmed/17112845?dopt=Citation>

APA

Foote, C. J., Greer, W., Kiberd, B. A., Fraser, A., Lawen, J., Nashan, B., & Belitsky, P. (2006). MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients. TRANSPL P, 38(9), 2847-2849. [9]. http://www.ncbi.nlm.nih.gov/pubmed/17112845?dopt=Citation

Vancouver

Foote CJ, Greer W, Kiberd BA, Fraser A, Lawen J, Nashan B et al. MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients. TRANSPL P. 2006;38(9):2847-2849. 9.

Bibtex

@article{9dc94f38e08d4cd091767b79ce1a154a,
title = "MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.",
abstract = "BACKGROUND: Single nucleotide polymorphisms (SNPs) in the multidrug resistance (MDR1) gene correlate with the intestinal function of P-glycoprotein (PGP). PGP serves as a hydrophobic export pump that extrudes cyclosporine (CsA) across the luminal membrane thus preventing CsA absorption. These genetic variants may predict CsA exposure levels in the early posttransplantation period. METHODS: CsA absorption profiles were established in 75 renal transplant patients using total daily dose and body weight adjusted 4-hour area under the time-concentration curve, AUC(0-4)/mg dose/kg body weight, on posttransplant day 3. These patients were subsequently genotyped for C3435T and G2677T polymorphisms using real-time polymerase chain reaction. An analysis was conducted to assess the independent impact of C3435T and G2677T SNPs on CsA bioavailability. RESULTS: C3435T polymorphisms were found to be an independent predictor of CsA AUC(0-4)/mg dose/kg levels on postoperative day 3. An inverse correlation was found between the number of T alleles and AUC values such that every T allele was associated with an approximate 15% decrement in AUC(0-4)/mg dose/kg (P = .034). A similar nonsignificant trend was observed for G2677T polymorphisms. CONCLUSIONS: MDR1 SNPs are correlated with CsA exposure in the early post-transplant period. Polymorphisms, in conjunction with other criteria, may become a useful tool to optimize initial drug dosing in renal transplantation.",
author = "Foote, {C J} and W Greer and Kiberd, {B A} and A Fraser and J Lawen and Bj{\"o}rn Nashan and P Belitsky",
year = "2006",
language = "Deutsch",
volume = "38",
pages = "2847--2849",
journal = "TRANSPL P",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "9",

}

RIS

TY - JOUR

T1 - MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.

AU - Foote, C J

AU - Greer, W

AU - Kiberd, B A

AU - Fraser, A

AU - Lawen, J

AU - Nashan, Björn

AU - Belitsky, P

PY - 2006

Y1 - 2006

N2 - BACKGROUND: Single nucleotide polymorphisms (SNPs) in the multidrug resistance (MDR1) gene correlate with the intestinal function of P-glycoprotein (PGP). PGP serves as a hydrophobic export pump that extrudes cyclosporine (CsA) across the luminal membrane thus preventing CsA absorption. These genetic variants may predict CsA exposure levels in the early posttransplantation period. METHODS: CsA absorption profiles were established in 75 renal transplant patients using total daily dose and body weight adjusted 4-hour area under the time-concentration curve, AUC(0-4)/mg dose/kg body weight, on posttransplant day 3. These patients were subsequently genotyped for C3435T and G2677T polymorphisms using real-time polymerase chain reaction. An analysis was conducted to assess the independent impact of C3435T and G2677T SNPs on CsA bioavailability. RESULTS: C3435T polymorphisms were found to be an independent predictor of CsA AUC(0-4)/mg dose/kg levels on postoperative day 3. An inverse correlation was found between the number of T alleles and AUC values such that every T allele was associated with an approximate 15% decrement in AUC(0-4)/mg dose/kg (P = .034). A similar nonsignificant trend was observed for G2677T polymorphisms. CONCLUSIONS: MDR1 SNPs are correlated with CsA exposure in the early post-transplant period. Polymorphisms, in conjunction with other criteria, may become a useful tool to optimize initial drug dosing in renal transplantation.

AB - BACKGROUND: Single nucleotide polymorphisms (SNPs) in the multidrug resistance (MDR1) gene correlate with the intestinal function of P-glycoprotein (PGP). PGP serves as a hydrophobic export pump that extrudes cyclosporine (CsA) across the luminal membrane thus preventing CsA absorption. These genetic variants may predict CsA exposure levels in the early posttransplantation period. METHODS: CsA absorption profiles were established in 75 renal transplant patients using total daily dose and body weight adjusted 4-hour area under the time-concentration curve, AUC(0-4)/mg dose/kg body weight, on posttransplant day 3. These patients were subsequently genotyped for C3435T and G2677T polymorphisms using real-time polymerase chain reaction. An analysis was conducted to assess the independent impact of C3435T and G2677T SNPs on CsA bioavailability. RESULTS: C3435T polymorphisms were found to be an independent predictor of CsA AUC(0-4)/mg dose/kg levels on postoperative day 3. An inverse correlation was found between the number of T alleles and AUC values such that every T allele was associated with an approximate 15% decrement in AUC(0-4)/mg dose/kg (P = .034). A similar nonsignificant trend was observed for G2677T polymorphisms. CONCLUSIONS: MDR1 SNPs are correlated with CsA exposure in the early post-transplant period. Polymorphisms, in conjunction with other criteria, may become a useful tool to optimize initial drug dosing in renal transplantation.

M3 - SCORING: Zeitschriftenaufsatz

VL - 38

SP - 2847

EP - 2849

JO - TRANSPL P

JF - TRANSPL P

SN - 0041-1345

IS - 9

M1 - 9

ER -